AlgiPharma now features on the Cystic Fibrosis Foundation (CFF) drug development pipeline
About Philip Rye
This author has yet to write their bio.Meanwhile lets just say that we are proud Philip Rye contributed a whooping 13 entries.
Entries by Philip Rye
AlgiPharma secures new license agreement with NTNU for exclusive global rights.
AlgiPharma granted Orphan Drug designation by FDA
Phone: +47 67545770